Edgewise Therapeutics Inc (EWTX)
18.12
-0.06
(-0.33%)
USD |
NASDAQ |
May 17, 16:00
18.12
0.00 (0.00%)
After-Hours: 18:49
Edgewise Therapeutics 1 Year Total Returns (Daily): 94.23% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | 94.23% |
May 15, 2024 | 96.01% |
May 14, 2024 | 88.13% |
May 13, 2024 | 88.57% |
May 10, 2024 | 84.96% |
May 09, 2024 | 105.3% |
May 08, 2024 | 111.4% |
May 07, 2024 | 118.9% |
May 06, 2024 | 109.7% |
May 03, 2024 | 111.0% |
May 02, 2024 | 120.5% |
May 01, 2024 | 98.85% |
April 30, 2024 | 104.6% |
April 29, 2024 | 94.41% |
April 26, 2024 | 104.9% |
April 25, 2024 | 104.9% |
April 24, 2024 | 123.8% |
April 23, 2024 | 105.4% |
April 22, 2024 | 97.90% |
April 19, 2024 | 130.4% |
April 18, 2024 | 144.5% |
April 17, 2024 | 139.7% |
April 16, 2024 | 186.2% |
April 15, 2024 | 183.6% |
April 12, 2024 | 184.7% |
Date | Value |
---|---|
April 11, 2024 | 188.8% |
April 10, 2024 | 162.9% |
April 09, 2024 | 153.0% |
April 08, 2024 | 163.8% |
April 05, 2024 | 168.8% |
April 04, 2024 | 165.6% |
April 03, 2024 | 173.7% |
April 02, 2024 | 164.9% |
April 01, 2024 | 170.2% |
March 28, 2024 | 160.6% |
March 27, 2024 | 158.8% |
March 26, 2024 | 149.5% |
March 25, 2024 | 132.9% |
March 22, 2024 | 137.2% |
March 21, 2024 | 137.9% |
March 20, 2024 | 126.6% |
March 19, 2024 | 113.9% |
March 18, 2024 | 105.2% |
March 15, 2024 | 121.2% |
March 14, 2024 | 121.4% |
March 13, 2024 | 126.1% |
March 12, 2024 | 139.1% |
March 11, 2024 | 126.0% |
March 08, 2024 | 103.8% |
March 07, 2024 | 105.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.50%
Minimum
May 25 2022
188.8%
Maximum
Apr 11 2024
-10.68%
Average
-32.35%
Median
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | -11.00% |
PTC Therapeutics Inc | -37.21% |
Regenxbio Inc | -18.81% |
Catalyst Pharmaceuticals Inc | 31.10% |
Vertex Pharmaceuticals Inc | 27.67% |